Patriot Financial Group Insurance Agency’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-129
Closed -$1K 1340
2022
Q2
$1K Buy
+129
New +$1.63K ﹤0.01% 1919

Other funds holding DFTX

Patriot Financial Group Insurance Agency's DFTX Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Definium Therapeutics (DFTX) in Q3 2022, closing a stake of 129 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in DFTX in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 101 funds tracked by Wall St. Rank hold DFTX as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Definium Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 129 Definium Therapeutics shares in Q3 2022, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Definium Therapeutics in Q2 2022 and held it in 1 quarter.
  • Patriot Financial Group Insurance Agency's Definium Therapeutics position peaked at $1K in Q2 2022.
  • 101 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.